Nicole Marsh Selected Research

Phlebitis

4/2022	Risk factors for peripheral intravascular catheter-related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units.
4/2022	Intravenous antimicrobial administration through peripheral venous catheters - establishing risk profiles from an analysis of 5252 devices.
12/2021	Peripheral intravenous catheter failure: A secondary analysis of risks from 11,830 catheters.
3/2021	Inherent and modifiable risk factors for peripheral venous catheter failure during cancer treatment: a prospective cohort study.
12/2020	Peripheral intravenous catheter non-infectious complications in adults: A systematic review and meta-analysis.
5/2020	Smile - Secure my intravenous line effectively: A pilot randomised controlled trial of peripheral intravenous catheter securement in paediatrics.
1/2019	Effectiveness of insertion and maintenance bundles in preventing peripheral intravenous catheter-related complications and bloodstream infection in hospital patients: A systematic review.
10/2018	Expert versus generalist inserters for peripheral intravenous catheter insertion: a pilot randomised controlled trial.
7/2018	Phlebitis Signs and Symptoms With Peripheral Intravenous Catheters: Incidence and Correlation Study.
1/2018	Observational Study of Peripheral Intravenous Catheter Outcomes in Adult Hospitalized Patients: A Multivariable Analysis of Peripheral Intravenous Catheter Failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole Marsh Research Topics

Disease

17	Sepsis (Septicemia) 11/2022 - 09/2012
16	Phlebitis 04/2022 - 02/2014
15	Infections 11/2022 - 09/2012
6	Pain (Aches) 04/2022 - 05/2015
4	Wounds and Injuries (Trauma) 05/2020 - 01/2017
4	Flushing 01/2020 - 03/2014
3	Critical Illness (Critically Ill) 04/2022 - 01/2021
3	Neoplasms (Cancer) 03/2021 - 01/2021
3	Thrombosis (Thrombus) 01/2021 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 06/2015
1	Hypersensitivity (Allergy) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Arteritis 01/2021
1	Contact Dermatitis (Eczema, Contact) 09/2019
1	Thrombophlebitis 01/2019
1	Irritant Dermatitis 07/2018
1	Erythema 07/2018
1	Catheter-Related Infections 10/2017
1	Bacteremia 04/2017

Drug/Important Bio-Agent (IBA)

5	Polyvinyl Chloride (PVC)IBA 04/2022 - 03/2014
2	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2021 - 04/2017
1	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 04/2022
1	Nicardipine (Dagan)FDA LinkGeneric 04/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 04/2022
1	Pharmaceutical PreparationsIBA 04/2022
1	polihexanideIBA 01/2022
1	ChlorhexidineIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	N 30IBA 03/2021
1	2-Propanol (Isopropyl Alcohol)FDA LinkGeneric 01/2021
1	Polyurethanes (Polyurethane)IBA 09/2019
1	Floxacillin (Flucloxacillin)IBA 01/2018
1	Sodium Chloride FDA LinkGeneric 11/2015
1	Heparin (Liquaemin)FDA LinkGeneric 11/2015
1	N-acetyltryptophanamide (NATA)IBA 11/2015

Therapy/Procedure

32	Catheters 11/2022 - 09/2012
6	Vascular Access Devices (Arterial Line) 11/2022 - 11/2015
5	Therapeutics 03/2021 - 05/2015
3	Critical Care (Surgical Intensive Care) 01/2022 - 01/2021
3	Central Venous Catheters 01/2022 - 09/2016
2	Device Removal (Removal, Device) 11/2022 - 05/2015
2	Transjugular Intrahepatic Portasystemic Shunt 05/2020 - 01/2017
2	Length of Stay 09/2016 - 09/2015
1	Treatment Delay 03/2021
1	Intravenous Administration 11/2019
1	Cannula 01/2019
1	Duration of Therapy 09/2012